310 related articles for article (PubMed ID: 37834225)
1. Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer.
López-Mejía JA; Mantilla-Ollarves JC; Rocha-Zavaleta L
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834225
[TBL] [Abstract][Full Text] [Related]
2. Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts.
Roach CM; Bidne KL; Romoser MR; Ross JW; Baumgard LH; Keating AF
J Anim Sci; 2022 Jul; 100(7):. PubMed ID: 35772766
[TBL] [Abstract][Full Text] [Related]
3. [Role of LNK gene mutation in pathogenesis of myeloproliferative neoplasms-review].
Chen Y; Wu XQ; Han CS; Zhu P; Wei JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1309-12. PubMed ID: 24156456
[TBL] [Abstract][Full Text] [Related]
4. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
Lai SY; Johnson FM
Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
[TBL] [Abstract][Full Text] [Related]
5. Targeting the JAK/STAT Signaling Pathway for Breast Cancer.
Shao F; Pang X; Baeg GH
Curr Med Chem; 2021; 28(25):5137-5151. PubMed ID: 33290193
[TBL] [Abstract][Full Text] [Related]
6. FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway.
Wang L; Zhao D; Wang H; Wang L; Liu X; Zhang H
Int Immunopharmacol; 2021 Nov; 100():108117. PubMed ID: 34509933
[TBL] [Abstract][Full Text] [Related]
7. The Role of JAK-STAT Signaling Activation in Hypertrophied Ligamentum Flavum.
Delen E; Doğanlar O; Delen Ö; Doğanlar ZB; Kılınçer C
World Neurosurg; 2020 May; 137():e506-e516. PubMed ID: 32059970
[TBL] [Abstract][Full Text] [Related]
8. Prolactin-induced production of reactive oxygen species and IL-1β in leukocytes from the bony fish gilthead seabream involves Jak/Stat and NF-κB signaling pathways.
Olavarría VH; Sepulcre MP; Figueroa JE; Mulero V
J Immunol; 2010 Oct; 185(7):3873-83. PubMed ID: 20826756
[TBL] [Abstract][Full Text] [Related]
9. The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis.
Morris R; Butler L; Perkins A; Kershaw NJ; Babon JJ
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056081
[TBL] [Abstract][Full Text] [Related]
10. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms.
Liu J; Wang F; Luo F
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671504
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319
[TBL] [Abstract][Full Text] [Related]
12. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
13. GRAMD1B regulates cell migration in breast cancer cells through JAK/STAT and Akt signaling.
Khanna P; Lee JS; Sereemaspun A; Lee H; Baeg GH
Sci Rep; 2018 Jun; 8(1):9511. PubMed ID: 29934528
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of JAK/STAT pathway modulation in mood disorders.
Shariq AS; Brietzke E; Rosenblat JD; Pan Z; Rong C; Ragguett RM; Park C; McIntyre RS
Rev Neurosci; 2018 Dec; 30(1):1-7. PubMed ID: 29902157
[TBL] [Abstract][Full Text] [Related]
15. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
[TBL] [Abstract][Full Text] [Related]
16. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers.
Ni Y; Low JT; Silke J; O'Reilly LA
Front Immunol; 2022; 13():835997. PubMed ID: 35844493
[TBL] [Abstract][Full Text] [Related]
17. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
Yang X; Tang Z; Zhang P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
[TBL] [Abstract][Full Text] [Related]
18. Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications.
Park H; Lee S; Lee J; Moon H; Ro SW
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762066
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
[TBL] [Abstract][Full Text] [Related]
20. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.
Chang WH; Lai AG
Mol Med; 2019 Nov; 25(1):46. PubMed ID: 31684858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
